Deferred Tax Assets, Valuation Allowance of Niagen Bioscience, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Niagen Bioscience, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $40,467,000, a 8.6% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Niagen Bioscience, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $40,467,000 -$3,823,000 -8.6% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q4 2024 $44,290,000 -$2,101,000 -4.5% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q4 2023 $46,391,000 +$137,000 +0.3% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q4 2022 $46,254,000 +$2,891,000 +6.7% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q4 2021 $43,363,000 +$8,119,000 +23% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q4 2020 $35,244,000 +$65,557,000 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q4 2019 $30,313,000 -$52,245,000 -238% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $21,932,000 +$9,028,000 +70% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 $12,904,000 -$2,626,000 -17% 30 Dec 2017 10-K 07 Mar 2019 2018 FY
Q4 2016 $15,530,000 +$480,000 +3.2% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $15,050,000 +$29,719,000 02 Jan 2016 10-K 16 Mar 2017 2016 FY
Q4 2014 $14,669,000 -$27,030,000 -219% 03 Jan 2015 10-K 17 Mar 2016 2015 FY
Q4 2013 $12,361,000 +$1,732,000 +16% 28 Dec 2013 10-K 19 Mar 2015 2014 FY
Q4 2012 $10,629,000 +$4,136,000 +64% 29 Dec 2012 10-K 27 Mar 2014 2013 FY
Q4 2011 $6,493,000 31 Dec 2011 10-K 29 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.